Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosis in myeloma cell lines
- 1 August 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (8) , 962-970
- https://doi.org/10.1016/s0301-472x(01)00677-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- APOPTOSIS-INDUCED BY TRAIL AND TNF-α IN HUMAN MULTIPLE MYELOMA CELLS IS NOT BLOCKED BY BCL-2Cytokine, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractOncogene, 1999
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κBCurrent Biology, 1996
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Modulation of Interleukin-6-induced Plasma Protein Secretion in Hepatoma Cells by p53 SpeciesPublished by Elsevier ,1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984